𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Testing for minimal hepatic encephalopathy in the United States: An AASLD survey

✍ Scribed by Jasmohan Singh Bajaj; Ashkan Etemadian; Muhammad Hafeezullah; Kia Saeian

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
59 KB
Volume
45
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

QuantiFERON TB gold testing for tubercul
QuantiFERON TB gold testing for tuberculosis screening in an inflammatory bowel disease cohort in the United States
✍ Bashar J. Qumseya; Ashwin N. Ananthakrishnan; Sue Skaros; Michael Bonner; Mazen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

Background: Reactivation of latent Mycobacterium tuberculosis (TB) is a rare, yet devastating infectious complication associated with anti-tumor necrosis factor alpha (TNF-a) therapy. We evaluated the performance of the QuantiFERON TB Gold test (QFT-G) for TB screening in a cohort of inflammatory bo

Treatment recommendations for chronic he
Treatment recommendations for chronic hepatitis B: An evaluation of current guidelines based on a natural history study in the United States
✍ Myron John Tong; Carlos Hsien; Leeyen Hsu; Hai-En Sun; Lawrence Mitchell Blatt 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 2 views

Current guidelines for treatment of chronic hepatitis B include hepatitis B e antigen (HBeAg) status, levels of hepatitis B virus (HBV) DNA, and serum alanine aminotransferase (ALT) values in the setting of either chronic hepatitis or cirrhosis. Based on findings from a prospective study of hepatiti

How do physician assessments of patient
How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey
✍ Deborah A. Marshall; F. Reed Johnson; Nathalie A. Kulin; Semra Özdemir; Judith M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 1 views

## Abstract __Background__: Patient preferences can affect colorectal cancer (CRC) screening test use. We compared utility‐based preferences for alternative CRC screening tests from a stated‐preference discrete‐choice survey of the general population and physicians in Canada and the United States.